Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02716272 |
|---|---|
| Brief Title: | Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients (MAPS2) |
| First Submitted : | March 9, 2016 |
| First Submitted that Met QC Criteria : | March 17, 2016 |
| First Posted : | March 23, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 9, 2021 |
| Last Update Posted : | February 10, 2021 |